New eye injection restores sight in untreatable hypotony
View as a Web Page
News Medical
 
  Ophthalmology & Optometry Ophthalmology & Optometry logo  
  The latest ophthalmology / optometry news from News Medical  
 Research breakthrough could provide a new, non-invasive way to assess retinal healthResearch breakthrough could provide a new, non-invasive way to assess retinal health
 
For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has recorded a tiny mechanical "twitch" in living human and rodent eyes at the exact moment a rod photoreceptor detects light.
 
 
 New eye injection restores sight in untreatable hypotonyNew eye injection restores sight in untreatable hypotony
 
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at University College London (UCL) and Moorfields Eye Hospital.
 
   Non-coding RNA mutations unveiled as new cause of retinitis pigmentosaNon-coding RNA mutations unveiled as new cause of retinitis pigmentosa
 
Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with night blindness in youth and progresses to tunnel vision as daylight-sensing photoreceptor cells in the retina gradually die, potentially leading to blindness over time.
 
   RNA gene mutations identified as cause of inherited blindnessRNA gene mutations identified as cause of inherited blindness
 
Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited blindness.
 
   Cardiovascular risk scores predict future development of serious eye diseasesCardiovascular risk scores predict future development of serious eye diseases
 
A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who will develop serious eye diseases years later.
 
 Trial finds no benefit of anti-inflammatory therapy in trachomatous trichiasis surgery
 
Trial finds no benefit of anti-inflammatory therapy in trachomatous trichiasis surgeryJohn Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is the lead author of a paper published in The Lancet Global Health, "Evaluation of fluorometholone as adjunctive medical therapy for trachomatous trichiasis surgery (FLAME): a parallel, double-blind, randomised controlled field trial in the Jimma Zone, Ethiopia."
 
 
 Greenland shark eyesight offers clues to longevity, vision, and healthy aging
 
Dorota Skowronska-Krawczyk sits in her office, eyes fixed on the computer monitor in front of her.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026